Suggest Clopidogrel Plus Aspirin in Most ACS Patients After a Coronary Stent

November 2017

You'll face questions about whether it's okay for patients to switch antiplatelets after a coronary stent.

Current guidelines prefer dual antiplatelet therapy with aspirin plus ticagrelor (Brilinta) or prasugrel (Effient, etc) after an acute coronary syndrome (ACS)...instead of aspirin plus clopidogrel (Plavix, etc).

Earlier studies suggest that ticagrelor or prasugrel reduces the risk of a recurrent CV event more than clopidogrel.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Blood Products Ask Jehovah's Witness Patients if They Will Accept Blood-Derived Products
Nephrology Help Put Risk of Contrast-Associated Acute Kidney Injury in Perspective
New Drugs Don't Use Delafloxacin to Treat Most Skin Infections
Gastroenterology Don't Assume Instructions to Swallow Inhaled Steroids Are an Error
Kidney Disease Think About Gabapentin for Severe Itching Due to Chronic Kidney Disease
Antiplatelets Suggest Clopidogrel Plus Aspirin in Most ACS Patients After a Coronary Stent
Interactions Schedule All Oral Meds Apart From Potassium Binders
New Drugs Don't Expect the New Gout Med Duzallo to Be on Your Formulary
Pregnancy Promote Safe Opioid Use in Pregnant Women
Practice Explain When Study Results Are Clinically Meaningful to Patients
Dosage Forms Watch for Dosing Differences With the New Spironolactone Suspension CaroSpir

Suggest Clopidogrel Plus Aspirin in Most ACS Patients After a Coronary Stent

Get unlimited access through an Enterprise license

Table of Contents